Csenge Advisory Group’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-54,039
| Closed | -$8.23M | – | 692 |
|
|
2025
Q1 | $8.23M | Buy |
54,039
+2,304
| +4% | +$351K | 0.47% | 42 |
|
|
2024
Q4 | $8.6M | Buy |
51,735
+988
| +2% | +$164K | 0.47% | 39 |
|
|
2024
Q3 | $8.74M | Buy |
50,747
+5,320
| +12% | +$916K | 0.46% | 42 |
|
|
2024
Q2 | $7M | Buy |
45,427
+26,703
| +143% | +$4.11M | 0.4% | 45 |
|
|
2024
Q1 | $2.88M | Sell |
18,724
-1,455
| -7% | -$224K | 0.16% | 114 |
|
|
2023
Q4 | $3.19M | Buy |
20,179
+283
| +1% | +$44.7K | 0.2% | 92 |
|
|
2023
Q3 | $2.91M | Buy |
19,896
+964
| +5% | +$141K | 0.2% | 95 |
|
|
2023
Q2 | $2.9M | Buy |
18,932
+5,609
| +42% | +$859K | 0.19% | 100 |
|
|
2023
Q1 | $2.07M | Buy |
13,323
+9,376
| +238% | +$1.45M | 0.15% | 125 |
|
|
2022
Q4 | $608K | Buy |
+3,947
| New | +$608K | 0.05% | 300 |
|
|
2020
Q3 | – | Sell |
-10,292
| Closed | -$1.73M | – | 406 |
|
|
2020
Q2 | $1.73M | Buy |
+10,292
| New | +$1.73M | 0.25% | 77 |
|